感染首次关节翻修术后急性肾损伤:危险因素与抗生素剂量的影响
回顾性分析247例因髋或膝关节假体周围感染行两阶段翻修术的患者,首次翻修术后急性肾损伤发生率为26%。体重指数较高、基线血红蛋白较低及存在合并症是急性肾损伤的显著危险因素;骨水泥间隔物中万古霉素或妥布霉素剂量较高未增加急性肾损伤风险。骨水泥间隔物中万古霉素剂量每增加1个单位,1年和2年感染未清除的比值降低至0.82倍。
要点
- 首次关节翻修术后急性肾损伤发生率为26%。
- 体重指数较高、基线血红蛋白较低及存在合并症是急性肾损伤的显著危险因素。
- 骨水泥间隔物中万古霉素剂量每增加1个单位,1年和2年感染未清除的比值降低至0.82倍。
核心结论
- 假体周围感染首次翻修术后急性肾损伤的发生率高于既往报道。
- 对已识别危险因素的患者应谨慎管理,关注血红蛋白水平,以避免术后急性肾损伤。
- 需要进一步研究以确定最佳局部抗生素类型和剂量,以最大化感染清除并最小化潜在副作用。
研究设计与样本
- 回顾性识别247例因髋或膝关节假体周围感染行两阶段翻修术的患者。
- 采用既往发表的急性肾损伤诊断标准确定其发生率及危险因素。
主要发现
- 首次关节翻修术后急性肾损伤发生率为26%。
- 体重指数较高与急性肾损伤风险相关(OR 1.07;95%CI 1.01-1.13;P = .02)。
- 基线血红蛋白较低与急性肾损伤风险相关(OR 0.70;95%CI 0.51-0.96;P = .03)。
- 存在合并症与急性肾损伤风险相关(OR 2.67;95%CI 1.26-5.64;P = .01)。
- 骨水泥间隔物中万古霉素剂量较高未增加急性肾损伤风险(OR 0.99;95%CI 0.88-1.11;P = .83);妥布霉素剂量较高亦未增加风险(OR 0.89;95%CI 0.77-1.04;P = .15)。
关键数值与推荐
- 骨水泥间隔物中万古霉素剂量每增加1个单位,1年和2年感染未清除的比值降低至0.82倍(95%CI 0.70-0.95;P = .01)。
临床怎么用
- 对已识别急性肾损伤危险因素的患者应谨慎管理,关注血红蛋白水平。
- 作者认为需要进一步研究以确定最佳局部抗生素类型和剂量。
局限性
- 需要进一步研究以确定最佳局部抗生素类型和剂量,以最大化感染清除并最小化潜在副作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Scarce literature exists regarding risk factors associated with postoperative acute kidney injury (AKI) after first-stage revision procedures. The purpose of this study was to determine risk factors for AKI and the efficacy of intra-articular antibiotics in infection eradication. METHODS: We retrospectively identified 247 patients who underwent a 2-stage revision procedure for the treatment of hip or knee periprosthetic joint infection. We applied previously published diagnostic criteria for AKI to determine its incidence and risk factors for its development. RESULTS: A 26% incidence of AKI was found after first-stage joint revision for infection. Higher body mass index (odds ratio [OR], 1.07; 95% confidence interval [CI], 1.01-1.13; P = .02), lower baseline hemoglobin level (OR, 0.70; 95% CI, 0.51-0.96; P = .03), and existence of a comorbid condition (OR, 2.67; 95% CI, 1.26-5.64; P = .01) were significant risk factors for AKI. Neither a higher dose of vancomycin (OR, 0.99; 95% CI, 0.88-1.11; P = .83) nor tobramycin (OR, 0.89; 95% CI, 0.77-1.04; P = .15) used in the cement spacer increased the risk of AKI. Each unit increase in vancomycin dose in the cement spacer decreased the odds of failing to clear the infection at 1 and 2 years by a factor of 0.82 (95% CI, 0.70-0.95; P = .01). CONCLUSION: AKI after first-stage revision procedures for periprosthetic joint infection occurs more commonly than previously reported. Patients with identified risk factors should be managed carefully with attention paid to hemoglobin levels, to avoid AKI after this procedure. Further research is needed to determine the optimal local antibiotic type and dosing to maximize infection clearance and minimize potential side effects.
引用
- Geller JA, Cunn G, Herschmiller T, et al. Acute Kidney Injury After First-Stage Joint Revision for Infection: Risk Factors and the Impact of Antibiotic Dosing. J Arthroplasty. 2017. PMID: 28578840. doi:10.1016/j.arth.2017.04.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。